Trial Profile
The efficacy and safety of oral Beclomethasone dipropionate (BDP) in patients with gastrointestinal acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary) ; Prednisone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 22 May 2013 New trial record